+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dyslipidemia Drug"

Dyslipidemia - Pipeline Insight, 2024 - Product Thumbnail Image

Dyslipidemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Dyslipidemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyslipidemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Disease Analysis: Dyslipidemia - Product Thumbnail Image

Disease Analysis: Dyslipidemia

  • Report
  • November 2020
  • 101 Pages
  • Global
Dyslipidemia Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Dyslipidemia Epidemiology Analysis and Forecast to 2032

  • Report
  • May 2023
  • 57 Pages
  • Global
From
Dyslipidemia Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Dyslipidemia Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 1398 Pages
  • Global
From
Dyslipidemia - Competitive Landscape in 2021 - Product Thumbnail Image

Dyslipidemia - Competitive Landscape in 2021

  • Report
  • June 2021
  • 51 Pages
  • Global
From
Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020 - Product Thumbnail Image

Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 50 Pages
  • Global
From
Dyslipidemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dyslipidemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 345 Pages
  • Global
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Dyslipidemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of dyslipidemia, a condition characterized by abnormal levels of lipids in the blood. Dyslipidemia drugs are used to reduce the risk of cardiovascular disease, stroke, and other cardiovascular complications. These drugs are typically administered orally and can be divided into two categories: statins and non-statin drugs. Statins are the most commonly prescribed drugs for dyslipidemia, as they are effective in reducing cholesterol levels. Non-statin drugs, such as fibrates, bile acid sequestrants, and cholesterol absorption inhibitors, are also used to treat dyslipidemia. The Dyslipidemia Drug market is highly competitive, with many large pharmaceutical companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more